A breakthrough chewable chlorogenic acid tablet designed to support immunity, cellular vitality, and metabolism.
Hong Kong — On September 11, 2025, at the Hong Kong Convention and Exhibition Centre, the world will witness the official debut of OROJIN. This breakthrough oral chewable tablet system redefines the way people approach their health. The launch at BIOHK 2025, one of the world’s most influential biotechnology gatherings, signals the beginning of a new era in preventive medicine. More than a supplement, OROJIN delivers a potent daily dose of chlorogenic acid that supports immunity, cellular vitality and promotes metabolic harmony. A “Daily Act of Self-Respect”, OROJIN was created to empower people everywhere to live stronger, healthier, and more fulfilled lives.
Developed in collaboration with leading professors and medical pioneers from the Miskawaan Health Group (MHG) and Jiuzhang Biotech, OROJIN is built on advanced research into chlorogenic acid (CHA), one of nature’s most potent antioxidant compounds. Extracted from Eucommia leaves using a comprehensive, proprietary system, its extensively researched benefits include:
Neutralizing free radicals that damage DNA and accelerate aging
Calming chronic inflammation, the root cause of many diseases
Restoring healthy cell signalling and boosting natural energy production
Protecting vital organs, including the heart, liver, gut, and brain
Encouraging restful sleep, and supporting memory and focus
With OROJIN, science becomes simple, accessible, and actionable in everyday life. “OROJIN is not just another product — it is the beginning of a movement,” said David Boehm Chariman of OROJIN. “This launch represents a mindset shift, encouraging people to take a proactive interest and care in their own health and wellbeing journey. We are delighted to be part of a new and empowered approach to wellness that starts with daily proactive care”, he added. Global Launch Celebration at BIOHK 2025 The unveiling of OROJIN will be David Boehm, Chairman of OROJIN and Miskawaan Health Group and Chairman Zhang of Jiuzhang Biotech (manufacture of OROJIN). It will be marked by:
Grand Red Ribbon Cutting Ceremony — the official moment OROJIN enters the world stage
Expert Insights — distinguished professors share the vision and science behind the product
Cultural Icon — the world will meet the OROJIN PreventaPanda, a beloved symbol of proactive health. With its warm smile and protective stance, PreventaPanda embodies the spirit of prevention — reminding every generation that the best medicine is the one you take before you need it.
OROJIN is the world’s first complete preventive wellness system, built on decades of scientific research and inspired by the belief that prevention is the highest form of care. Designed for global impact, OROJIN empowers individuals everywhere to live longer, stronger, and with self-respect.
Miskawaan Health Group (MHG) is a global integrative health organisation with deep German roots, combining the precision of German medical standards with the principles of functional and natural medicine. MHG provides personalised, science-based treatments that address the root causes of disease and is recognised for its expertise in preventive healthcare, cancer care support, longevity, and regenerative medicine. Delivered through world-class physicians and state-of-the-art diagnostic facilities, Miskawaan Health Group is dedicated to helping individuals achieve long-term vitality, resilience, and quality of life.
Founded in 1995 and established in Chengdu China, Jiuzhang Biotech is a pioneer in botanical medicine and natural product research. With more than 80 patents in proprietary extraction technologies, the company integrates traditional Chinese medicine with modern biotechnology to deliver pharmaceutical-grade raw materials and science-backed wellness solutions for global markets.
For All Enquiries, please contact:
Cat Lam
OROJIN
Director of Sales and Marketing
Email: Cat@orojinhealth.com
Phone: +852 51849568
Website: www.orojinhealth.com